Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry — Jacek Migaj (2018) | RDL Network
Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry
Article 2018 en
Authors
JM
Jacek Migaj
MK
Marta Kałużna‐Oleksy
JN
Jadwiga Nessler
Abstract
1 min read
Digoxin is associated with increased risk of death in HFrEF patients without AF history receiving the guideline- -directed treatment. Digoxin seems to be employed in patients with worse clinical status, which may at least partially explain its association with increased risk of death.
Monika Budnik, Monika Gawałko, Piotr Lodziński, Agata Tymińska, Krzysztof Ozierański, Marcin Grabowski, Michał Peller, Anna Wancerz, Marek Kiliszek, Grzegorz Opolski, Radosław Lenarczyk, Zbigniew Kalarus, Professor Gregory Lip, Paweł Balsam
Krzysztof Ozierański, Agnieszka Kapłon‐Cieślicka, Paweł Balsam, Agata Tymińska, Anna Wancerz, Michał Peller, Michał Marchel, María G. Crespo‐Leiro, Aldo Maggioni, Jarosław Dróżdż, Krzysztof J. Filipiak, Grzegorz Opolski
Giuseppe Boriani, Marco Proietti, C Laroche, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gaita Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.